Managing Nausea and Other GLP-1 Side Effects: A Practical Guide for Chicago Patients
Digestive side effects are the most common reason people struggle early on a GLP-1. These everyday strategies may help, and your provider can adjust your plan.
Blog
Wegovy vs. Zepbound for Chicago Adults: How the Two Weight Loss Medications Compare
Wegovy (semaglutide) and Zepbound (tirzepatide) are both FDA-approved for chronic weight management. Here is how they differ and how a Chicago telehealth visit can help you decide.
Eating on a GLP-1: Protein, Hydration and Muscle Preservation for Chicago Adults
GLP-1 medications turn down appetite, which makes what you do eat matter more: protein, fluids, fiber, and strength training all help protect muscle and how you feel while weight comes down. Here is a practical, physician-reviewed overview for Chicago-area adults.
Weight Loss Doctor in Chicago: In-Person vs. Online Obesity Medicine Care
Chicago adults looking for a weight loss doctor can choose between an in-person office and an online obesity medicine practice, and each format has real strengths. Here is how to compare them and decide which fits your health needs, schedule, and goals.
Online Weight Loss Doctor in Illinois: How Telehealth GLP-1 Care Works for Chicago-Area Adults
An online weight loss doctor can evaluate your health history, discuss FDA-approved medications, and monitor your progress over secure video visits, so Chicago-area adults can get physician-supervised care without commuting to an office. Here is what a telehealth visit involves and how to choose a provider.
Does Insurance Cover Weight Loss Medication in 2026?
Many Chicago-area adults exploring medical weight loss for the first time want to know one thing before they book a consultation: will insurance pay for the medication. The answer varies by plan, diagnosis, and the specific drug prescribed, and it rarely comes down to a simple yes or no.
Is There an Oral Zepbound? What Chicago Patients Should Know About Foundayo (Orforglipron), Eli Lilly’s New Weight Loss Pill
Zepbound remains a once-weekly injection (tirzepatide). However, Eli Lilly, the maker of Zepbound, received FDA approval on April 1, 2026 for Foundayo™ (orforglipron), a once-daily oral GLP-1 weight loss pill that can be taken any time of day, with or without food. If you were searching for “oral Zepbound,” Foundayo is almost certainly the medication you were looking for.
Oral Wegovy Is Here: What Chicago Patients Should Know About the First GLP-1 Weight Loss Pill
For years, the biggest question we heard from patients across Chicago and the western suburbs — from the Loop to Naperville to Oak Brook — was some version of: “Is there a pill version of Wegovy? I just can’t do injections.” As of January 2026, the answer is finally yes. The FDA approved the Wegovy® pill (oral semaglutide) in December 2025...
Affordable Ozempic & Wegovy — Now $349/Month for Semaglutide Weight Loss Care at TeleSlim Clinic Chicago
TeleSlim Clinic now offers a lower‑cost semaglutide option that makes Ozempic and Wegovy more attainable for many people in the Chicago area. For $349 per month, our subscription model aims to reduce financial hurdles while keeping physician oversight central to care.
How TrumpRx Makes GLP-1 Weight Loss Medications More Affordable — What Chicago Patients Need to Know
The federal pricing initiative known as TrumpRx is changing how certain high cost anti obesity drugs are priced and distributed, opening clearer, lower cost routes for Chicago patients to access GLP 1 and GIP therapies.